rxstatShortages › Olanzapine

Olanzapine shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Olanzapine products are in shortage in Canada (1 of 106 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 7, 2026.
Products affected
1 / 106
In shortage since
Jun 30, 2026
Est. full return
Aug 7, 2026
Reports on file
328
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-OLANZAPINE ODT
5MG · TABLET (ORALLY DISINTEGRATING) · APOTEX INC
DIN 02360616 · since Jun 30, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Anticipated
OLANZAPINE ODT
5MG · TABLET (ORALLY DISINTEGRATING) · SANIS HEALTH INC
DIN 02352974 · Disruption of the manufacture of the drug.
Anticipated
OLANZAPINE ODT
10MG · TABLET (ORALLY DISINTEGRATING) · SANIS HEALTH INC
DIN 02352982 · Disruption of the manufacture of the drug.
Resolved
TEVA-OLANZAPINE
20MG · TABLET · TEVA CANADA LIMITED
DIN 02359707 · ended Mar 18, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP OLANZAPINE ODT
10MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02406632 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP OLANZAPINE ODT
15MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02406640 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP OLANZAPINE ODT
20MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02406659 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP OLANZAPINE ODT
5MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02406624 · ended Mar 30, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-OLANZAPINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02276747 · ended May 31, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-OLANZAPINE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02276747 · ended Jun 3, 2026 · Disruption of the manufacture of the drug.
Resolved
APO-OLANZAPINE
2.5MG · TABLET · APOTEX INC
DIN 02281791 · ended May 22, 2026 · Disruption of the manufacture of the drug.
Resolved
ZYPREXA ZYDIS
15MG · TABLET (ORALLY DISINTEGRATING) · CHEPLAPHARM REGISTRATION GMBH
DIN 02243088 · ended Apr 6, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Olanzapine is currently affected by an active shortage report filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Olanzapine is classified under “ANTIPSYCHOTICS” (ATC N05AH).

Recent changes

Common questions

When will Olanzapine be back in stock in Canada?

The latest manufacturer estimate is Aug 7, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Olanzapine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antipsychotics)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.